Endogenous SIRT6 in platelets negatively regulates platelet activation and thrombosis.
MAPK
SIRT6
cardiovascular-related disease
platelet activation
thrombosis
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2023
2023
Historique:
received:
28
07
2023
accepted:
07
12
2023
medline:
8
1
2024
pubmed:
8
1
2024
entrez:
8
1
2024
Statut:
epublish
Résumé
Thromboembolism resulting from platelet dysfunction constitutes a significant contributor to the development of cardiovascular disease. Sirtuin 6 (SIRT6), an essential NAD
Identifiants
pubmed: 38186648
doi: 10.3389/fphar.2023.1268708
pii: 1268708
pmc: PMC10766690
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1268708Informations de copyright
Copyright © 2023 Liu, Wang, Zhou, Xin, Niu, Li, Wang, Li, Dong, Zhang, Feng, Fu, Zhang and Huang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.